SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation, part III: influence of penetration enhancer on diffusion and permeation of model drugs
- PMID: 22771971
- DOI: 10.1016/j.ijpharm.2012.06.044
SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation, part III: influence of penetration enhancer on diffusion and permeation of model drugs
Abstract
The impact of the lipophilic penetration enhancer, oleic acid (OA), on the barrier properties of stratum corneum (SC) lipid model membranes was investigated based on diffusion and permeation studies of model drugs covering a broad range of lipophilicities. Diffusion and permeation experiments of urea, caffeine and diclofenac sodium were conducted using Franz-type diffusion cells. HPLC and capillary electrophoresis techniques were employed to analyze the amount of permeated drug. An incorporation of OA to the SC lipid model membranes did not change the relation between the diffusion and permeation behavior of model drugs presented previously for SC lipid model membranes without OA. The fastest rate of diffusion through SC lipid model membranes occurred in the case of the most hydrophilic drug, urea. In the case of permeation studies of caffeine and diclofenac sodium across SC lipid model systems, the permeability parameters were either equal or slightly larger in favor of the most lipophilic drug, diclofenac sodium. OA had a pronounced impact on the barrier properties of SC lipid model membranes. It caused the impairment of the barrier function of the SC lipid model membrane with Cer [AP] (phytosphingosine-based ceramide), however, surprisingly improved the barrier properties of the SC lipid model system with Cer [EOS] (sphingosine-based acylceramide).
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.Eur J Pharm Biopharm. 2012 Oct;82(2):360-6. doi: 10.1016/j.ejpb.2012.06.008. Epub 2012 Jun 30. Eur J Pharm Biopharm. 2012. PMID: 22750439
-
Characterization of lipid model membranes designed for studying impact of ceramide species on drug diffusion and penetration.Eur J Pharm Biopharm. 2012 May;81(1):113-20. doi: 10.1016/j.ejpb.2012.02.002. Epub 2012 Mar 6. Eur J Pharm Biopharm. 2012. PMID: 22418075
-
Controlled penetration of ceramides into and across the stratum corneum using various types of microemulsions and formulation associated toxicity studies.Eur J Pharm Biopharm. 2014 Feb;86(2):244-50. doi: 10.1016/j.ejpb.2013.07.011. Epub 2013 Jul 27. Eur J Pharm Biopharm. 2014. PMID: 23896195
-
Properties of ceramides and their impact on the stratum corneum structure. Part 2: stratum corneum lipid model systems.Skin Pharmacol Physiol. 2008;21(2):58-74. doi: 10.1159/000112956. Epub 2008 Jan 11. Skin Pharmacol Physiol. 2008. PMID: 18187965 Review.
-
[Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].Acta Pharm Hung. 2012;82(1):15-22. Acta Pharm Hung. 2012. PMID: 22570983 Review. Hungarian.
Cited by
-
Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the Stratum Corneum.Mol Pharm. 2023 Jul 3;20(7):3278-3297. doi: 10.1021/acs.molpharmaceut.3c00126. Epub 2023 Jun 6. Mol Pharm. 2023. PMID: 37279070 Free PMC article. Review.
-
Chemical Enhancer: A Simplistic Way to Modulate Barrier Function of the Stratum Corneum.Adv Pharm Bull. 2018 Jun;8(2):169-179. doi: 10.15171/apb.2018.021. Epub 2018 Jun 19. Adv Pharm Bull. 2018. PMID: 30023318 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical